BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2444889)

  • 21. Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.
    Niespodziana K; Cabauatan CR; Pazderova P; Vacal PC; Wortmann J; Keller W; Errhalt P; Valenta R
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody neutralization epitopes and integrin binding sites on nonenveloped viruses.
    Nemerow GR; Stewart PL
    Virology; 2001 Sep; 288(2):189-91. PubMed ID: 11601890
    [No Abstract]   [Full Text] [Related]  

  • 23. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
    Altmeyer R; Murdin AD; Harber JJ; Wimmer E
    Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2.
    Speller SA; Sangar DV; Clarke BE; Rowlands DJ
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():193-200. PubMed ID: 8381460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic relationships of common rhinovirus types from disabling upper respiratory illnesses.
    Mogabgab WJ; Holmes BJ; Pollock B
    Dev Biol Stand; 1975; 28():400-11. PubMed ID: 165120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.
    Katpally U; Fu TM; Freed DC; Casimiro DR; Smith TJ
    J Virol; 2009 Jul; 83(14):7040-8. PubMed ID: 19403680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody interactions with rhinovirus: lessons for mechanisms of neutralization and the role of immunity in viral evolution.
    Smith TJ
    Curr Top Microbiol Immunol; 2001; 260():1-28. PubMed ID: 11443870
    [No Abstract]   [Full Text] [Related]  

  • 28. Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity.
    Sam Narean J; Glanville N; Nunn CM; Niespodziana K; Valenta R; Johnston SL; McLean GR
    Vaccine; 2019 May; 37(21):2805-2813. PubMed ID: 31003914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of the human rhinovirus C capsid suggests a novel topography with insights on receptor preference and immunogenicity.
    Basta HA; Sgro JY; Palmenberg AC
    Virology; 2014 Jan; 448():176-84. PubMed ID: 24314648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Rhinovirus Neutralisation by Antibodies.
    Touabi L; Aflatouni F; McLean GR
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33668934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The canyon hypothesis.
    Rossmann MG
    Viral Immunol; 1989; 2(3):143-61. PubMed ID: 2560913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic groupings of 90 rhinovirus serotypes.
    Cooney MK; Fox JP; Kenny GE
    Infect Immun; 1982 Aug; 37(2):642-7. PubMed ID: 6288568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.
    Che Z; Olson NH; Leippe D; Lee WM; Mosser AG; Rueckert RR; Baker TS; Smith TJ
    J Virol; 1998 Jun; 72(6):4610-22. PubMed ID: 9573224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility.
    Smith TJ; Olson NH; Cheng RH; Chase ES; Baker TS
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7015-8. PubMed ID: 8394005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of human rhinovirus immunogenic epitopes for rational vaccine design.
    Stepanova E; Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2019 Sep; 18(9):877-880. PubMed ID: 31416365
    [No Abstract]   [Full Text] [Related]  

  • 36. Production and properties of site-specific antibodies to synthetic peptide antigens related to potential cell surface receptor sites for rhinovirus.
    McCray J; Werner G
    Methods Enzymol; 1989; 178():676-92. PubMed ID: 2557528
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses.
    Colonno RJ; Callahan PL; Long WJ
    J Virol; 1986 Jan; 57(1):7-12. PubMed ID: 3001366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of a human common cold virus and functional relationship to other picornaviruses.
    Rossmann MG; Arnold E; Erickson JW; Frankenberger EA; Griffith JP; Hecht HJ; Johnson JE; Kamer G; Luo M; Mosser AG
    Nature; 1985 Sep 12-18; 317(6033):145-53. PubMed ID: 2993920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhinovirus infections in chronic bronchitis: isolation of eight possibly new rhinovirus serotypes.
    Scott EJ; Grist NR; Eadie MB
    J Med Microbiol; 1968 Aug; 1(1):109-17. PubMed ID: 4318937
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for at least two dominant neutralization antigens on human rhinovirus 14.
    Sherry B; Rueckert R
    J Virol; 1985 Jan; 53(1):137-43. PubMed ID: 2981332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.